Abstract:This study aimed to assess the renopreventive effect of enalapril and/or paricalcitol on streptozotocin (STZ) diabetes-induced nephropathy and to elucidate their mechanisms of action through investigation of the effects on renal oxidative stress, antioxidant defense system and expressions of TNF-α, p53, caspase-3, and Bcl-2. Diabetes mellitus was induced in fasting male Wistar rats by single intraperitoneal injection of STZ (45 mg /kg b.w.) dissolved in citrate buffer (pH 4.5). Ten days after STZ injection, the diabetic rats were treated with enalapril (25 mg/l of drinking water) and/or paricalcitol (8 μg/kg b.w. per os) dissolved in 5% DMSO daily for 4 weeks. The obtained data revealed that the treatment of diabetic Wistar rats with enalapril and/or paricalcitol led to significant decreases in the elevated serum urea, uric acid, creatinine, sodium and potassium levels; thereby reflecting the improvement of the impaired kidney function. The deteriorated kidney lipid peroxidation, GSH content and GST and catalase activities in diabetic rats were significantly ameliorated as a result of treatment with enalapril and/or paricalcitol. The elevated fasting and post-prandial serum glucose levels and the lowered serum insulin and C-peptide levels were also improved. The treatment with enalapril and paricalcitol in combination was the most potent in decreasing the elevated serum glucose levels. Moreover, the treatment of diabetic rats successfully prevented the diabetes-induced histopathological deleterious changes of kidney and islets of Langerhans of pancreas. In association, the immunohistochemically detected pro-inflammatory cytokine, TNF-α, and apoptotic mediators, p53 and caspase-3, were remarkably decreased in kidney of diabetic rats as a result of treatment while the expression of anti-apoptotic protein Bcl-2 was increased. Based on these findings, it can be concluded that enalapril and paricalcitol alone or in combination can prevent STZ diabetes-induced nephropathy through amelioration of the glycemic state and antioxidant defense system together with the suppression of oxidative stress, inflammation and apoptosis. However, the treatment of diabetic rats with enalapril and paricalcitol in combination has no further significant improvement effects on renal function and damage when compared with enalapril or paclitaxel treated diabetic groups.

The Renal Protective Effects of Cilostazol on Suppressing Pathogenic Thrombospondin-1 and Transforming Growth Factor-β Expression in Streptozotocin-Induced Diabetic Rats

Effects of Cilostazol on Thrombospondin-1 (TSP-1) Expression Changes in the Myocardium of Diabetic Rats.

The Effect of Cilostazol on Expression of Thrombospondin-1 in Diabetic Retinopathy.

Investigation of Inhibition of Thrombospondin-1 ( TSP-1 ) Expression by Puerarin in Kidney of Diabetic

Expression Changes of Transforming Growth Factor-Beta1 and Thrombospondin-1 in Cavernous Tissues of Diabetic Rats.

Xuezhikang (Eeuroe",A(0)Center Dot) Reduced Renal Cell Apoptosis In Streptozocin-Induced Diabetic Rats Through Regulation Of Bcl-2 Family

Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats

Xuezhikang (血脂康) reduced renal cell apoptosis in streptozocin-induced diabetic rats through regulation of Bcl-2 family

Changes of TGF - β1 , Vimentin and Desmin Gene Expression in the Renal Cortex of Streptozotocin - induced Diabetic Rats

Effects of Angiotensin-Ii Receptor Blockers on Β-Catenin Expression in a Rat Model of Experimental Streptozotocin-Induced Early-Stage of Diabetic Nephropathy

Peripheral Nerve Denervation in Streptozotocin-Induced Diabetic Rats Is Reduced by Cilostazol

Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin.

Cilostazol Ameliorates Motor Dysfunction and Schwann Cell Impairment in Streptozotocin-Induced Diabetic Rats

Cilostazol Ameliorates Peripheral Neuropathic Pain in Streptozotocin-Induced Type I Diabetic Rats

[Effect of Compound Rhizoma Coptidis Capsule on Expression of Transforming Growth Factor-Beta1 and Type IV Collagen Proteins in Renal Tissue of Diabetic Rats with Nephropathy].

Effects of Panax notoginoside on the expression of TGF-β1 and Smad-7 in renal tissues of diabetic rats

The Effect of Angitensin Converting Inhibitor and Angiotensin Ⅱ Receptor Antagonist on Experimental Diabetic Nephropathy-with Transforming Growth Factor Β1

Effects of Pioglitazone on MKP-1 and TSP-1 Expression in Early Stages of Diabetic Retinopathy Induced by Streptozotocin

Tiliroside protects against diabetic nephropathy in streptozotocin-induced diabetes rats by attenuating oxidative stress and inflammation

20(S)-Ginsenoside Rg3 Protects Kidney from Diabetic Kidney Disease via Renal Inflammation Depression in Diabetic Rats

[Protective effects of compound shenhua tablet on diabetic nephropathy rats]